Breast Cancer and Genetics

The two most common genetic risk factors for breast cancer are the BRCA1 & BRCA2 genes. Approximately 5% of all breast cancers are caused by a recognised specific genetic predisposition due to germ line mutations of one of two different genes: BRCA1 located on Chromosome 17q, BRCA2 located on Chromosome 13q. BRCA1 mutations also predispose to carcinoma of the ovary and possibly carcinoma of the Fallopian tube. The risk of developing breast cancer among carriers is around 55% by age 70. BRCA2: The product of BRCA2 is involved in controlling gene function and DNA repair. Gene function involves in transcriptional activation and completion of cell division by cytokinesis.  Majority of BRCA2-associated tumours are invasive ductal, no special-type tumours

  • Testing for BRCA1 & 2
  • Ataxia telangiectasia mutation (ATM)
  • Hereditary breast cancers genes
  • Prognosis

Related Conference of Breast Cancer and Genetics

July 31 - August 1, 2019

International Conference on Surgical Pathology

Amsterdam,Netherlands
August 21-22, 2019

17th Asia Pacific Pathology Congress

Singapore
October 23-24, 2019

Lab Medpathology Conference 2019

Frankfurt, Germany
October 23- 24, 2019

International Conference on Molecular Pathology

Amsterdam | Netherlands
November 18-19, 2019

World Congress on Histopathology

Berlin, Germany
November 25-26, 2019

2nd European Pathology and Infectious Disease Conference

Helsinki, Finland
December 09-10, 2019

14th International Conference on Laboratory Medicine & Pathology

Kuala Lumpur, Malaysia

Breast Cancer and Genetics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in